Cindy Reiss-Clark - 21 Mar 2022 Form 3 Insider Report for WEST PHARMACEUTICAL SERVICES INC (WST)

Role
Senior Vice President
Signature
Roopali Hall, as agent for Reiss-Clark Cynthia K.
Issuer symbol
WST
Transactions as of
21 Mar 2022
Net transactions value
$0
Form type
3
Filing time
23 Mar 2022, 15:55:50 UTC
Next filing
23 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding WST Common Stock 3,350 21 Mar 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding WST Stock Options (Right to buy) 21 Mar 2022 Common Stock 4,909 $104.69 Direct F1
holding WST Stock Options (Right to buy) 21 Mar 2022 Common Stock 3,060 $102.51 Direct F2
holding WST Stock Options (Right to buy) 21 Mar 2022 Common Stock 2,868 $173.22 Direct F3
holding WST Stock Options (Right to buy) 21 Mar 2022 Common Stock 3,176 $274.29 Direct F4
holding WST Stock Options (Right to buy) 21 Mar 2022 Common Stock 3,108 $369.13 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This award vests in four equal annual installments beginning on October 19, 2019.
F2 This award vests in four equal annual installments beginning on February 19, 2020.
F3 This award vests in four equal annual installments beginning on February 18, 2021.
F4 This award vests in four equal annual installments beginning on February 23, 2022.
F5 This award vests in four equal annual installments beginning on February 22, 2023.